1.Organising services for IMD in Thailand: twenty years experience.
Annals of the Academy of Medicine, Singapore 2008;37(12 Suppl):117-113
The study of inherited metabolic disorders (IMD) in Thailand is in its infancy when compare with developed countries. Prior to 1987, majority of these disorders were clinically diagnosed since there were only a handful of clinicians and scientists with expertise in inborn errors of metabolism, lack of well-equipped laboratory facilities and government support. In developing countries, inherited metabolic disorders are not considered a priority due to the prevalence of infectious diseases such as HIV infection and congenital infections. A multicentre survey conducted in 1994 and 2001 revealed the existence of numerous cases of IMD from all over the country. Case reports and publications on IMD in Thai (and international) medical journals in past 20 years had undoubtedly raised its awareness among Thai paediatricians and scientists. In 2001, the Genetic Metabolic Centre was first established in Siriraj Hospital Faculty of Medicine, Thailand. Numerous new cases of IMD had been identified since then.
Child
;
Humans
;
Metabolism, Inborn Errors
;
diagnosis
;
epidemiology
;
genetics
;
Thailand
;
Time Factors
2.A Population-Based Genomic Study of Inherited Metabolic Diseases Detected Through Newborn Screening.
Kyoung Jin PARK ; Seungman PARK ; Eunhee LEE ; Jong Ho PARK ; June Hee PARK ; Hyung Doo PARK ; Soo Youn LEE ; Jong Won KIM
Annals of Laboratory Medicine 2016;36(6):561-572
BACKGROUND: A newborn screening (NBS) program has been utilized to detect asymptomatic newborns with inherited metabolic diseases (IMDs). There have been some bottlenecks such as false-positives and imprecision in the current NBS tests. To overcome these issues, we developed a multigene panel for IMD testing and investigated the utility of our integrated screening model in a routine NBS environment. We also evaluated the genetic epidemiologic characteristics of IMDs in a Korean population. METHODS: In total, 269 dried blood spots with positive results from current NBS tests were collected from 120,700 consecutive newborns. We screened 97 genes related to NBS in Korea and detected IMDs, using an integrated screening model based on biochemical tests and next-generation sequencing (NGS) called NewbornSeq. Haplotype analysis was conducted to detect founder effects. RESULTS: The overall positive rate of IMDs was 20%. We identified 10 additional newborns with preventable IMDs that would not have been detected prior to the implementation of our NGS-based platform NewbornSeq. The incidence of IMDs was approximately 1 in 2,235 births. Haplotype analysis demonstrated founder effects in p.Y138X in DUOXA2, p.R885Q in DUOX2, p.Y439C in PCCB, p.R285Pfs*2 in SLC25A13, and p.R224Q in GALT. CONCLUSIONS: Through a population-based study in the NBS environment, we highlight the screening and epidemiological implications of NGS. The integrated screening model will effectively contribute to public health by enabling faster and more accurate IMD detection through NBS. This study suggested founder mutations as an explanation for recurrent IMD-causing mutations in the Korean population.
Computational Biology
;
DNA/chemistry/isolation & purification/metabolism
;
Dried Blood Spot Testing
;
Galactokinase
;
Genomics
;
Haplotypes
;
High-Throughput Nucleotide Sequencing
;
Humans
;
Incidence
;
Infant, Newborn
;
Membrane Proteins/genetics
;
Metabolic Diseases/*diagnosis/epidemiology/genetics
;
Metabolism, Inborn Errors/diagnosis/epidemiology/genetics
;
Mitochondrial Membrane Transport Proteins/genetics
;
Neonatal Screening
;
Polymorphism, Genetic
;
Republic of Korea/epidemiology
;
Sequence Analysis, DNA
3.Advances in the clinical and laboratory studies on methylmalonic aciduria combined with homocysteinemia type cblC.
Chinese Journal of Pediatrics 2013;51(4):313-316
Adult
;
Age of Onset
;
Amino Acid Metabolism, Inborn Errors
;
complications
;
diagnosis
;
genetics
;
therapy
;
Betaine
;
administration & dosage
;
therapeutic use
;
Carrier Proteins
;
genetics
;
metabolism
;
Child
;
China
;
epidemiology
;
DNA Mutational Analysis
;
Gas Chromatography-Mass Spectrometry
;
Genotype
;
Homocysteine
;
urine
;
Humans
;
Hydroxocobalamin
;
administration & dosage
;
therapeutic use
;
Hyperhomocysteinemia
;
complications
;
diagnosis
;
genetics
;
therapy
;
Infant
;
Methylmalonic Acid
;
blood
;
urine
;
Mutation
;
Vitamin B 12
;
metabolism
4.Abnormal findings during newborn period of 160 patients with early-onset methylmalonic aciduria.
Yu-peng LIU ; Yan-yan MA ; Tong-fei WU ; Qiao WANG ; Xi-yuan LI ; Yuan DING ; Jin-qing SONG ; Yu HUANG ; Yan-ling YANG
Chinese Journal of Pediatrics 2012;50(6):410-414
OBJECTIVEMethylmalonic aciduria is the most common disorder of organic acidurias in the mainland of China. It is also the one of treatable metabolic disorders. The clinical spectrum of the patients varies from severe neonatal-onset forms with neonatal brain injury and high mortality to milder forms with adult-onset. The clinical manifestations of neonates with methylmalonic aciduria are non-specific. Early diagnosis and adequate treatment contribute a lot to improving the prognosis of the patients. In this study, the abnormal clinical and laboratory findings in neonatal period of 160 Chinese patients with early-onset methylmalonic aciduria were investigated.
METHODFrom 1996 to 2011, a total of 398 patients with methylmalonic aciduria were diagnosed in our hospital; 286 (71.9%) patients had early-onset before 1 year of age. Among 286 patients, 160 (55.9%) presented symptoms in neonatal period. Their urine organic acids were analyzed by gas chromatography-mass spectrometry. Blood amino acids and acylcarnitine profiles were determined by liquid chromatography tandem mass spectrometry. Serum and urine total homocysteine were measured using a fluorescence polarization immunoassay. In some patients, gene analysis was performed. Based on the disease types and general condition, individual dietary and medical interventions were started soon after diagnosis.
RESULTOut of the 160 patients, 131 (81.9%) had combined methylmalonic aciduria and homocysteinemia. Isolated methylmalonic aciduria was found in 29 cases (18.1%). The common presentations in neonatal period were feeding difficulty, seizures, lethargy and dyspnea. Megaloblastic anemia, liver dysfunction, hyperammonemia and metabolic acidosis were the frequent findings in the routine laboratory test. The most common initial clinical diagnosis was suspected hypoxic-ischemic encephalopathy. Even in 36 cases with abnormal family history, only 3 patients were admitted with suspected inborn errors of metabolism. Five cases (3.1%) were diagnosed by postmortem metabolic examination; 7 cases (4.4%) were detected by newborn screening. In 148 cases (92.5%), the diagnosis was much delayed to the age of one month to 8 years and 5 months (mean 13 months). Methylmalonic aciduria combined with homocysteinemia (MMACHC) gene analyses were performed in 31 cases with combined methylmalonic aciduria. CblC defect was confirmed. The patients with isolated methylmalonic aciduria were treated with protein-restricted diet, cobalamin and L-carnitine. The patients of methylmalonic aciduria combined with homocysteinemia were treated with cobalamin, L-carnitine, calcium folinate, betaine and common diet. Seven patients died without treatment. Clinical improvement was observed in 153 patients. Only 2 patients detected by newborn screening had normal mental and physical development. Mild to severe psychomotor retardation was observed in 151 cases.
CONCLUSIONHigh mortality and disability rates were observed in the patients with early-onset methylmalonic aciduria. Combined methylmalonic aciduria and homocysteinemia is the common type of methylmalonic aciduria. The clinical manifestation in neonatal period of the patients with early-onset methylmalonic aciduria is complex. Feeding difficulty, seizures, lethargy and dyspnea are the common symptoms in neonatal period of the patients. Megaloblastic anemia, liver dysfunction, hyperammonemia and metabolic acidosis were the frequent laboratory findings.
Amino Acid Metabolism, Inborn Errors ; complications ; diagnosis ; genetics ; therapy ; Carnitine ; therapeutic use ; Child ; Child, Preschool ; China ; epidemiology ; Female ; Folic Acid ; therapeutic use ; Gas Chromatography-Mass Spectrometry ; Homocysteine ; blood ; urine ; Humans ; Hyperhomocysteinemia ; diagnosis ; etiology ; therapy ; Infant ; Infant, Newborn ; Male ; Methylmalonic Acid ; urine ; Neonatal Screening ; Retrospective Studies ; Vitamin B 12 ; therapeutic use